| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |